Stephanie Ronning

Title: Stephanie Ronning: Innovator in Recombinant Trypsin Production

Introduction

Stephanie Ronning is a notable inventor based in Penzberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 3 patents to her name, her work has implications for various applications in medical and research settings.

Latest Patents

One of her latest patents is a method for producing recombinant trypsin from porcine pancreas. This innovative method ensures that trypsin is soluble and secreted into the culture medium. By expressing at a pH of 3.0-4.0, her method substantially prevents the activation of trypsinogen to β-trypsin and the subsequent autolysis of β-trypsin by α-trypsin into ε-trypsin and inactive peptides. This advancement is crucial for enhancing the efficiency and safety of trypsin production.

Career Highlights

Stephanie Ronning is currently employed at Roche Diagnostics Operations, Inc., where she continues to develop her innovative ideas. Her work at Roche has allowed her to focus on cutting-edge research and development in the field of diagnostics and biotechnology.

Collaborations

Throughout her career, Stephanie has collaborated with esteemed colleagues such as Johann-Peter Thalhofer and Rainer Muller. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in biotechnology.

Conclusion

Stephanie Ronning is a pioneering inventor whose work in recombinant trypsin production showcases her expertise and dedication to advancing biotechnology. Her contributions are vital to the ongoing development of effective medical and research applications.